Prévisions du marché européen des dispositifs de neurostimulation jusqu\'en 2030 – Analyse régionale – par produit (stimulateur de la moelle épinière, stimulateur cérébral profond, stimulateur du nerf sacré, stimulateur du nerf vague et autres), application (gestion de la douleur, épilepsie, incontinence urinaire et fécale, maladie de Parkinson maladie et autres) et utilisateur final (hôpitaux, cliniques spécialisées et autres)

Le marché européen des appareils de neurostimulation était évalué à 1 717,84 millions de dollars américains en 2022 et devrait atteindre 3 459,24 millions de dollars américains d’ici 2030 ; on estime qu’il enregistrera un TCAC de 9,1 % de 2022 à 2030. L’augmentation des cas de lésions de la moelle épinière alimente le marché européen des dispositifs de neurostimulation L’industrie des dispositifs de neurostimulation a gagné du terrain en raison de l’augmentation de la population âgée sujette à divers troubles de la colonne vertébrale. Cette population est de plus en plus susceptible de développer des troubles de la colonne vertébrale tels que les discopathies dégénératives, l\'arthrose, la scoliose, la tumeur de la colonne vertébrale et la sténose de la colonne vertébrale. À mesure que cette population vieillit, l’usure naturelle de la colonne vertébrale peut entraîner plusieurs troubles de la colonne vertébrale. Par conséquent, le vieillissement de la population pose un défi unique aux chirurgiens de la colonne vertébrale en raison d’une fragilité accrue, de comorbidités médicales, d’une diminution de l’état nutritionnel et d’une probabilité plus élevée de complications postopératoires. Selon les données de l\'Organisation mondiale de la santé (OMS) publiées en octobre 2022, environ 80 % de la population âgée vivra dans des pays à revenu faible ou intermédiaire d\'ici 2050, et il est prévu que le rythme du vieillissement de cette population soit très rapide. plus vite que par le passé. Le vieillissement démographique, associé à des facteurs liés au mode de vie, a conduit à une augmentation substantielle du nombre de personnes souffrant de problèmes de colonne vertébrale tels que la discopathie dégénérative et les déformations de la colonne vertébrale. Par conséquent, l’incidence élevée de lésions de la moelle épinière chez les personnes âgées et chez les adultes stimule la demande d’appareils de neurostimulation. Aperçu du marché européen des appareils de neurostimulation Le marché européen des appareils de neurostimulation est segmenté au Royaume-Uni, en Allemagne, en France, en Italie, en Espagne et dans le reste de l\'Europe. Le marché régional devrait croître considérablement dans les années à venir en raison de la prévalence croissante de troubles neurologiques tels que les anévrismes cérébraux, les accidents vasculaires cérébraux et autres et de l’augmentation des innovations de produits apportées par les acteurs du marché opérant dans la région. La croissance du marché est également attribuée au développement des systèmes de santé dans des pays comme l\'Allemagne, la France et l\'Espagne et à l\'augmentation du lancement de produits innovants par des entreprises régionales clés. En juin 2020, Medtronic a annoncé le lancement du neurostimulateur PerceptTM PC doté de la technologie BrainsenseTM. La technologie enregistre et délivre simultanément des stimulations électriques au cerveau pour soulager les symptômes de la maladie de Parkinson (MP). Revenus et prévisions du marché européen des appareils de neurostimulation jusqu\'en 2030 (en millions de dollars américains) Segmentation du marché européen des appareils de neurostimulation Le marché européen des appareils de neurostimulation est segmenté en fonction du produit, de l\'application, de l\'utilisateur final et du pays. En fonction du produit, le marché européen des appareils de neurostimulation est segmenté en stimulateur de la moelle épinière, stimulateur cérébral profond, stimulateur du nerf sacré, stimulateur du nerf vague et autres. Le segment des stimulateurs de la moelle épinière détenait la plus grande part de marché en 2022. En termes d’application, le marché européen des appareils de neurostimulation est classé en gestion de la douleur, épilepsie, incontinence urinaire et fécale, maladie de Parkinson et autres. Le segment de la gestion de la douleur détenait la plus grande part de marché en 2022. Par utilisateur final, le marché européen des appareils de neurostimulation est segmenté en hôpitaux, cliniques spécialisées et autres. Le segment des hôpitaux détenait la plus grande part de marché en 2022. En fonction des pays, le marché européen des appareils de neurostimulation est segmenté entre le Royaume-Uni, l’Allemagne, la France, l’Italie, l’Espagne et le reste de l’Europe. L\'Allemagne a dominé la part de marché des appareils de neurostimulation en Europe en 2022. Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc et Mainstay Medical font partie des principales sociétés opérant sur le marché européen des appareils de neurostimulation. .

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Neurological Disorders

4.1.2 Rising Cases of Spinal Cord Injury

4.2 Market Restraints

4.2.1 Lack of Expert Professionals

4.3 Market Opportunities

4.3.1 Growing Advances and Approvals for Neurostimulation Devices

4.4 Future Trends

4.4.1 Rising Demand for Noninvasive Treatment

4.5 Impact Analysis

5. Neurostimulation Devices Market - Europe Market Analysis

5.1 Europe Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Spinal Cord Stimulator

6.3.1 Overview

6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Deep Brain Stimulator

6.4.1 Overview

6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Sacral Nerve Stimulator

6.5.1 Overview

6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vagus Nerve Stimulator

6.6.1 Overview

6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Pain Management

7.3.1 Overview

7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Epilepsy

7.4.1 Overview

7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Urinary and Fecal Incontinence

7.5.1 Overview

7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Parkinson's Disease

7.6.1 Overview

7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Specialty Clinics

8.4.1 Overview

8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Europe: Neurostimulation Devices Market

9.1.1 Overview

9.1.2 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

9.1.2.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott Laboratories

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Nevro Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 LivaNova Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Synapse Biomedical Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 ElectroCore Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Mainstay Medical

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Neurostimulation Devices Market Segmentation

Table 2. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 3. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 4. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 5. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 6. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 12. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 13. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 15. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, Neurostimulation Devices Market

List of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country

Figure 2. Neurostimulation Devices Market: Key Industry Dynamics

Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints

Figure 4. Europe Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)

Figure 22. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

Figure 23. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

1. Medtronic Plc

2. Boston Scientific Corp

3. Abbott Laboratories

4. Nevro Corp

5. LivaNova Plc

6. Synapse Biomedical Inc

7. ElectroCore Inc

8. Mainstay Medical

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe neurostimulation devices market.

Highlights key business priorities in order to assist companies to realign their business strategies

The key findings and recommendations highlight crucial progressive industry trends in the Europe neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe neurostimulation devices market, as well as those hindering it

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For Europe Neurostimulation Devices Market

WHAT'S INCLUDED IN FULL REPORT